All, this chart sucks in all honestly, but think we are looking at a reversal here, needs to hold exact level it's at before moving up or may drop down one level bounce and should break out the top. Either way WW this week/next.
B or X Wave. Recovery within a recovery.
This is a reflection using technical analysis + only and we do not consider valuation and macro factors at this stage.
The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels...
Support line
Entry 1.65
Stop 1.25
Target 3.3
I am not a PRO trader. I trade option to test my trading plan with small cost.
The max Risk of each plan is less than 1% of my account.
If you like this idea, please use SIM/Demo account to try it.
Bought this yesterday with the following reasons:
1. Stoch RSI at oversold level
2. Fibo and extended fibo retracement levels are followed
3. Realistic target prices
4. Tolerable cutloss level
Bought at 2, targetting 2.36 in two trading days! If it breaks 2.36 next week, I guess this stock will ride a rocket. Newbie trader here :)
This one has a nice impulse up and it starting to look like it will continue that move. Once breaking out of the larger degree structure it looks like some positive buying is happening now.
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.
NASDAQ:GERN
Possible Scenario: LONG
Evidence: Price Action
This is my idea and could be wrong 100%
* It's a good buy opportunity right now, and it's ready to fly soon.
GERN, waiting for the breakkout I highlight this lateral phase that has lasted for several months, within what seems to me a triangle in which the title has already passed the half of the figure
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.
New management, improvement in balance sheets convinced me. Sector is also outperforming. And now cup with handle pattern setup on chart. Looks like There is a strong resistance at current price, But I'm bullish. Target price = $4.5.
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
NASDAQ
